The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Alendronate may relate to the incidence of cancers, especially esophageal and colon cancer. But the results are inconsistent in different studies.
To quantify the association between the use of alendronate and the occurrence of different types of cancer.
We searched Embase, Pubmed, CENTRAL, SIGLE and clinicaltrials.gov, up to 2014 June.
Co...
Alternative Titles
Full title
The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1673824225
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1673824225
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0123080
